ABBV-CLS-579

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameABBV-CLS-579
Drug Alias NameABBV-CLS-579
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein phosphatase non-receptor type 2 inhibitors
TargetsTyrosine-protein phosphatase non-receptor type 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanFrance +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCalico Life Sciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesCalico Life Sciences LlcAbbvie Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A